2020
DOI: 10.1200/jgo.19.00205
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Utility of a Hand-Held Scanner for Breast Cancer Early Detection and Patient Triage

Abstract: PURPOSE Globally, breast cancer represents the most common cause of cancer death among women. Early cancer diagnosis is difficult in low- and middle-income countries, most of which are unable to support population-based mammographic screening. Triage on the basis of clinical breast examination (CBE) alone can be difficult to implement. In contrast, piezo-electric palpation (intelligent Breast Exam [iBE]) may improve triage because it is portable, low cost, has a short learning curve, and provides electronic do… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
7
0
2

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 26 publications
2
7
0
2
Order By: Relevance
“…Thus, the clinical utility of a hand-held breast scanner (intelligent Breast Exam [iBE] shows promising results for women. 41…”
Section: Implications For Community Practicementioning
confidence: 99%
“…Thus, the clinical utility of a hand-held breast scanner (intelligent Breast Exam [iBE] shows promising results for women. 41…”
Section: Implications For Community Practicementioning
confidence: 99%
“…Initial iBreastExam studies [19][20][21][22][23][24] are promising, reporting 84-87% sensitivity, 80-94% specificity, and high negative predictive values (NPV; 94-98%). The iBreastExam can possibly provide a standardised breast examination with a report to facilitate physician communication.…”
Section: Introductionmentioning
confidence: 99%
“… 7 The WHO does not currently endorse any strategy of population breast cancer screening in LMICs, finding mammography not cost effective in that context, 16 and other technologies such as piezoelectric-based handheld devices require further study in LMIC contexts prior to widespread clinical implementation. 17 , 18 However, the WHO suggests CBE screening could be useful in settings it is shown to be effective and sustainable and where appropriate diagnostic and treatment services are available.…”
Section: Introductionmentioning
confidence: 99%